{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:56:26Z","timestamp":1793174186779,"version":"4.5.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075091","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T17:09:19Z","timestamp":1379696959000},"page":"e75091","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":463,"title":["Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases"],"prefix":"10.1371","volume":"8","author":[{"given":"Johanna","family":"Gaiottino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Norgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Topping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahuva","family":"Nissim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Bestwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas U.","family":"Monsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Regeniter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija L.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Kappos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"A Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis","volume":"12","author":"J Brettschneider","year":"2006","journal-title":"Mult Scler"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2009.02595.x","article-title":"EFNS guidelines on disease-specific CSF investigations","volume":"16","author":"F Deisenhammer","year":"2009","journal-title":"Eur J Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1352458510361358","article-title":"Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'","volume":"16","author":"G Giovannoni","year":"2010","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"M Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2010.01.004","article-title":"A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein","volume":"220","author":"J Kuhle","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","article-title":"Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis","volume":"76","author":"J Kuhle","year":"2011","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","article-title":"A specific ELISA for measuring neurofilament heavy chain phosphoforms","volume":"278","author":"A Petzold","year":"2003","journal-title":"J Immunol Methods"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21239","article-title":"CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barre syndrome","volume":"40","author":"A Petzold","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"N Norgren","year":"2003","journal-title":"Brain Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3181a0fe3f","article-title":"Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis","volume":"72","author":"CE Teunissen","year":"2009","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","article-title":"Neurofilament and glial fibrillary acidic protein in multiple sclerosis","volume":"63","author":"N Norgren","year":"2004","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/jcbfm.2008.12","article-title":"Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients","volume":"28","author":"SB Lewis","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"J Ganesalingam","year":"2011","journal-title":"J Neurochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","article-title":"Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"KB Boylan","year":"2013","journal-title":"J Neurol Neurosurg, Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/jnnp.2003.017236","article-title":"Axonal degeneration and inflammation in acute optic neuritis","volume":"75","author":"A Petzold","year":"2004","journal-title":"J Neurol Neurosurg, Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1191\/1352458504ms1021sr","article-title":"Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis","volume":"10","author":"A Petzold","year":"2004","journal-title":"Mult Scler"},{"key":"ref18","first-page":"217802","article-title":"The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies","author":"A Petzold","year":"2012","journal-title":"Mult Scler Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/cc11244","article-title":"Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest","volume":"16","author":"M Rundgren","year":"2012","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"157le8","DOI":"10.1126\/scitranslmed.3004403","article-title":"Comment on "chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model"","volume":"4","author":"M Tisdall","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ana.22169","article-title":"Evidence for acute neurotoxicity after chemotherapy","volume":"68","author":"A Petzold","year":"2010","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2011.01.025","article-title":"Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke","volume":"304","author":"P Singh","year":"2011","journal-title":"J Neurol Sci"},{"key":"ref23","first-page":"S0167","article-title":"Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest","author":"OR Rana","year":"2012","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/15368590252917647","article-title":"Monoclonal antibodies selective for low molecular weight neurofilaments","volume":"21","author":"N Norgren","year":"2002","journal-title":"Hybrid Hybridomics"},{"key":"ref25","article-title":"A comparative study of CSF neurofilament light and heavy chain protein in MS","author":"J Kuhle","year":"2013","journal-title":"Mult Scler"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.50.3.768","article-title":"Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group","volume":"50","author":"MA Ross","year":"1998","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2010.11.026","article-title":"A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect","volume":"195","author":"CH Lu","year":"2011","journal-title":"J Neurosci Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"J Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/17482968.2011.627589","article-title":"Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS","volume":"13","author":"M Otto","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.brainresbull.2005.06.031","article-title":"Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis. Brain","volume":"67","author":"N Norgren","year":"2005","journal-title":"Res Bull"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"LE Rosengren","year":"1996","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","article-title":"Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype","volume":"14","author":"H Zetterberg","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref34","first-page":"1352458512458010","article-title":"CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome","volume":"19","author":"M Khalil","year":"2012","journal-title":"Mult Scler"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","article-title":"Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury","volume":"336","author":"G Shaw","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1471-4159.2009.06386.x","article-title":"Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker","volume":"111","author":"K Boylan","year":"2009","journal-title":"J Neurochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s11064-011-0553-8","article-title":"Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign","volume":"36","author":"J Sellner","year":"2011","journal-title":"Neurochem Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2012.11.021","article-title":"The neuropathology and neurobiology of traumatic brain injury","volume":"76","author":"K Blennow","year":"2012","journal-title":"Neuron"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/01.wnl.0000237334.69665.92","article-title":"CSF neurofilament levels: a potential prognostic marker in Guillain-Barre syndrome","volume":"67","author":"A Petzold","year":"2006","journal-title":"Neurology"},{"key":"ref40","article-title":"Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barre syndrome","author":"I Dujmovic","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000091436","article-title":"The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer\u2019s disease","volume":"21","author":"J Brettschneider","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000101843","article-title":"A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia","volume":"4","author":"A Petzold","year":"2007","journal-title":"Neurodegener Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:21:25Z","timestamp":1540308085000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075091"}},"subtitle":[],"editor":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075091","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}